1. Home
  2. OLMA vs GVH Comparison

OLMA vs GVH Comparison

Compare OLMA & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • GVH
  • Stock Information
  • Founded
  • OLMA 2006
  • GVH 2016
  • Country
  • OLMA United States
  • GVH Australia
  • Employees
  • OLMA N/A
  • GVH N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • GVH
  • Sector
  • OLMA Health Care
  • GVH
  • Exchange
  • OLMA Nasdaq
  • GVH Nasdaq
  • Market Cap
  • OLMA 465.4M
  • GVH N/A
  • IPO Year
  • OLMA 2020
  • GVH 2023
  • Fundamental
  • Price
  • OLMA $6.10
  • GVH $0.64
  • Analyst Decision
  • OLMA Strong Buy
  • GVH
  • Analyst Count
  • OLMA 5
  • GVH 0
  • Target Price
  • OLMA $26.25
  • GVH N/A
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • GVH 22.3K
  • Earning Date
  • OLMA 11-12-2024
  • GVH 02-15-2025
  • Dividend Yield
  • OLMA N/A
  • GVH N/A
  • EPS Growth
  • OLMA N/A
  • GVH 67.24
  • EPS
  • OLMA N/A
  • GVH 0.11
  • Revenue
  • OLMA N/A
  • GVH $17,570,748.00
  • Revenue This Year
  • OLMA N/A
  • GVH N/A
  • Revenue Next Year
  • OLMA N/A
  • GVH N/A
  • P/E Ratio
  • OLMA N/A
  • GVH $5.93
  • Revenue Growth
  • OLMA N/A
  • GVH N/A
  • 52 Week Low
  • OLMA $5.56
  • GVH $0.47
  • 52 Week High
  • OLMA $16.78
  • GVH $2.57
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • GVH 38.16
  • Support Level
  • OLMA $5.56
  • GVH $0.66
  • Resistance Level
  • OLMA $6.87
  • GVH $0.69
  • Average True Range (ATR)
  • OLMA 0.81
  • GVH 0.04
  • MACD
  • OLMA -0.28
  • GVH -0.00
  • Stochastic Oscillator
  • OLMA 10.12
  • GVH 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: